Interview: Olia Vassileva – Executive Director, Bulgarian Association of…
Olia Vassileva, executive director at the Bulgarian Association of Pharmaceutical Wholesalers (BAPW), gives a clear…
BAPW
Last updated: 13.02.2014
Address: 90 Long Acre London WC2E 9RA,United Kingdom
Tel: +44 (0)20 7031 0590
Web: http://www.bapw.net/
Company description
The BAPW represents full line pharmaceutical distributors who between them provide 90% of the nation’s medicines, covering all of the UK’s population. We provide a forum for discussion across the industries involved in the provision of pharmaceuticals to Britain’s health services.
Products and services
BAPW act as the link between manufacturers and doctors, pharmacists and hospitals, taking delivery of medicines; storing them safely and securely until they are needed by customers; then delivering them, as required, quickly and efficiently to wherever they are needed by patients. But full-line wholesalers don’t just provide a simple supply service:
• They stock the entire range of 20,000 licensed medicines, ready for dispatch at any time
• They operate around the clock, around the year
• They provide around half of all the computer equipment used in pharmacies;
They offer banking, merchandising and business development advice to pharmacists.
Interviews
Related
Global / Is Everything So Wrong at GSK?
British pharmaceuticals giant, GSK, one of the UK’s largest companies by market capitalization, is once again…
Kathy Pritchard-Jones – President, International Society of Paediatric…
Kathy Pritchard-Jones, Professor of Paediatric Oncology at University College London (UCL) and President of the…
Zack Pemberton-Whiteley – CEO, Leukaemia Care
Zack Pemberton-Whiteley, CEO of UK-based blood cancer charity Leukaemia Care, discusses the importance of patient…
Europe / Vaccine Wars: What the EU/AstraZeneca Row Shows Us About Pharma Cross-Border Litigation
Stuart Evans, partner at law firm BLM and specialist in commercial disputes and litigation examines the origins and…
UK / Fastest Growing Private Pharmacos; GSK Shake-Up; Brexit Uncertainties; COVID-19 Reinfection Trial
The latest UK pharma news, including how new investment in GSK stands to reshape the country’s iconic pharma…
M&A / Jazz’s $7.2 Billion GW Pharma Deal: A Major Boost for Cannabinoid Research
The first day of March 2013 also marked a first for GW Pharmaceuticals. On that day, the British biopharmaceutical…
UK / New Post-Brexit Regulatory Alliance with Australia, Canada, Singapore & Switzerland
When the European Medicines Agency (EMA) relocated from London to Amsterdam after the UK announced its decision to…
UK-Japan FTA / Banishing UK Pharma's Brexit Blues
The signing of an agreement on the terms of a future trade relationship between Japan and the UK has been welcomed…
UK / MSD to Build USD 1.3 Billion London Research Hub in Boon for Post-Brexit Britain
US Merck (MSD globally) is following through on a 2017 commitment to invest in a new early research hub in central…
Opinion / 3 Ways the UK’s Pharma Sector is Driving Innovation
Jameel Zayed of Leyton, the UK’s leading innovation funding consultancy, highlights the British pharmaceutical…
News Roundup / UK Pharma May 2020
Below we highlight some recent developments in pharma and healthcare in the UK, including drug shortages in British…
Coronavirus / GSK & Sanofi’s Unprecedented COVID-19 Vaccine Collaboration
The world’s two leading vaccine producers, GSK of the UK and France’s Sanofi, last week announced that they are…
